透過合併進行私有化 就東風汽車集團股份有限公司的股份的交易披露 2025 年 12 月 8 日 執行人員接獲依據香港《公司收購及合併守則》規則 22 作出以下的證券交易的披露： 交易在美國交易所進行。 交易披露 完 註： BlackRock, Inc.憑藉持有受要約公司的普通股，所以根據第(6)類別屬受要約公司的聯繫人。 交易是為全權委託投資客戶的帳戶進行的。 | 交易方 | 日期 | | | 買入／賣 | 股份數目 | | 每股價格 | | 交易後數額（包括與其訂 | 佔該類別證券的百分比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 出 | | | | | 有協議或達成諒解的任 | （包括與其訂有協議或 | | | | | | | | | | | 何人士的證券） | 達成諒解的任何人士的 | | | | | | | | | | | | 證券）% | | BlackRock, Inc. | 2025 | 年 | 12 月 | 賣出 | | 9,390,030 | | $9.1900 | 121, ...

Core Insights - The domestic passenger car retail market in China experienced a decline in November, with retail volume at 2.225 million units, down 8.1% year-on-year and a slight decrease of 1.1% month-on-month. Cumulatively, from January to November, retail sales reached 21.483 million units, reflecting a year-on-year growth of 6.1% [1] - The market dynamics show a pattern of "high at the beginning, stable later, and pressure in the fourth quarter," influenced by high base figures from the previous year and a gradual return to normal growth [1] - The "old-for-new" subsidy policy significantly supported market growth earlier in the year, but its impact is diminishing as subsidies are phased out, leading to a decrease in daily subsidy applications [1] Passenger Car Market Performance - In November, the wholesale sales of new energy vehicles (NEVs) saw 22 manufacturers surpassing 10,000 units, contributing 94.2% to total NEV sales, indicating a concentration in the market [2] - Major domestic brands like BYD, Geely, and Chery led the sales, with respective volumes of 475,000, 188,000, and 112,000 units [2] - The "second-generation" new energy brands are gaining momentum, with their market share reaching 14.65%, up 1.1 percentage points year-on-year [2] Export Trends - November marked a record high for passenger car exports at 601,000 units, a significant year-on-year increase of 52.4%. Domestic brands accounted for 525,000 units of this total [3] - Cumulatively, from January to November, exports of domestic brand NEVs reached 1.78 million units, a staggering increase of 139% year-on-year, with NEVs making up 40.6% of total exports [3] - The structure of NEV exports is improving, with the share of plug-in hybrid vehicles rising from 26% to 42% year-on-year [3] Promotional Activities and Market Dynamics - The anticipated year-end "tail effect" in the market did not materialize, although promotional activities remain strong, particularly for traditional fuel vehicles and NEVs [4] - In November, the average promotional discount for traditional fuel vehicles was stable at 24%, while NEVs saw an increase in promotional intensity, averaging 10.1% [4] - The average price reduction for new NEVs from January to November was 24,000 yuan, equating to 11.7% of the vehicle price [4] Inventory and Market Outlook - Due to weak retail performance in November, overall industry inventory increased by 60,000 units, contrasting sharply with a decrease of 220,000 units in the same month last year [5] - The inventory warning index for automotive dealers rose to 55.6%, indicating a decline in industry prosperity [5] - Looking ahead, the expiration of the NEV purchase tax exemption is expected to boost December sales but may create pressure for 2026, potentially leading to a "micro-growth" phase in the domestic market [6] Future Projections - Analysts predict that total passenger car wholesale sales will grow by approximately 2.9% in 2026, with NEVs expected to drive this growth with a projected increase of 19% [7] - The competitive landscape is set to intensify with 173 new models expected to launch, over 90% of which will be NEVs or offer NEV options [7] - The domestic market may enter a deep adjustment phase in 2026, with globalization becoming a critical factor for future automotive company trajectories [7]

Market Overview - The Hong Kong stock market experienced a volatile trading day on December 9, with the Hang Seng Index closing down 1.29% at 25,434.23 points, the Hang Seng Tech Index down 1.90% at 5,554.68 points, and the National Enterprises Index down 1.62% at 8,936.41 points [1] - Technology stocks generally declined, with notable drops in Bilibili, Xiaomi, and Baidu, each falling over 3%, while Kuaishou and Meituan dropped over 2% [1] - Gold and non-ferrous metal stocks faced pressure, with Zijin Mining down over 4% [1] - Real estate stocks weakened significantly, with Yaloo Group plunging over 18% [1] - The semiconductor sector saw substantial declines, with Huahong Semiconductor down over 5% and SMIC down over 4% [1] - New consumption concept stocks also fell, with Pop Mart down over 5% [1] - Pharmaceutical stocks performed well, with Genscript Biotech rising 18%, Hongteng Precision up 11%, and Zhaoyan New Drug up 5.9% [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a slight decrease of approximately 0.3% year-on-year, while new energy vehicle sales reached 489,203 units, marking a 39.1% increase [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [2] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a decline of 22.6% year-on-year [3] - Sunny Optical Technology completed a share swap merger with GoerTek, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [3] - Zoomlion Heavy Industry completed the acquisition of 81% of the shares in Zoomlion Heavy Industry Finance Leasing (Beijing) [4] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [5] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [6] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® was successfully renewed for inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug Xuanyue Ning® was included for the first time [6] - Yuan Da Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in a Phase II clinical study conducted in China [7] - Agile Group's hearing has been further postponed to March 9, 2026 [8] Institutional Insights - Bank of China International views the recent market adjustment as a normal phenomenon in a bull market, maintaining a positive outlook for the Hong Kong stock market, predicting the Hang Seng Index could reach 30,100 points by December 2026 [9] - Huaxia Fund believes that the previous irrational panic in the tech sector has eased, and with AI development paths becoming clearer, it is advisable to position for a recovery in the market [9] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its five-year average, indicating a reasonable valuation range, while the tech index has room for growth [9] - Guosen Securities suggests that the recent market adjustment opens up space for future growth, with significant net inflows from southbound funds into the Hong Kong market [10]

Market Overview - The US stock market experienced a collective decline, leading to a weak market sentiment in Hong Kong, with the Hang Seng Index down 0.84% to 25,549.90 points, the Hang Seng Tech Index down 1.32% to 5,587.69 points, and the National Enterprises Index down 1.12% to 8,981.84 points [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a year-on-year decrease of approximately 0.3%. New energy vehicle sales reached 489,203 units, marking a year-on-year increase of about 39.1% [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% year-on-year [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [3] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a year-on-year decline of 22.6% [4] - Sunyu Optical Technology completed a share swap merger with Goer Optical, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [4] - Zoomlion Heavy Industry completed the acquisition of 81% equity in Zoomlion Heavy Industry Finance Leasing (Beijing) [5] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [6] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [7] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® successfully renewed its inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug XuanYueNing® was included for the first time [7] - Yuanda Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in Phase II clinical trials in China [8] - Agile Group's hearing has been further postponed to March 9, 2026 [9] Institutional Insights - Haitong International suggests that after market consolidation, a rebound is expected, with technology stocks having room for recovery. The rebound's strength will depend on policy implementation and potential interest rate cuts by the Federal Reserve [10] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its 5-year average, indicating overall valuation recovery, while the tech index has just returned to its 5-year average, suggesting room for further valuation catch-up [10] - Guosen Securities predicts that the short-term adjustment in Hong Kong stocks opens up space for market growth in 2026, with net inflows from southbound funds exceeding 110 billion yuan in November [10]

Group 1 - The Central Political Bureau of the Communist Party of China held a meeting to analyze and study economic work for 2026, emphasizing the need for better coordination between domestic economic work and international trade struggles, and the implementation of more proactive macro policies [1] - The meeting proposed eight key "insistences" for economic work, highlighting the importance of expanding domestic demand and optimizing supply [1] - Experts indicated that the demand for economic growth transformation remains strong, and policies need to balance short-term and long-term goals, with domestic demand continuing to play a crucial role in economic recovery [1] Group 2 - The China Securities Regulatory Commission established legislative contact points to enhance market participation in capital market legislation, with six units designated as the first batch of contact points [4] - The International Monetary Fund's Shanghai Center officially opened, aimed at strengthening communication and cooperation with economies in the Asia-Pacific region [6] Group 3 - The National Financial Regulatory Administration emphasized the need for insurance companies to assess the sustainability of their business models as a regulatory focus, highlighting the importance of strategic direction and asset-liability management [8] - The latest data from the China Passenger Car Association indicated that domestic retail sales of new energy passenger vehicles reached 1.32 million units in November, a year-on-year increase of 4.2% [12] - TrendForce projected that global shipments of optical transceivers above 800G will reach nearly 63 million units by 2026, representing a growth rate of 2.6 times from 2025 [13] Group 4 - China Minmetals announced plans to sell assets worth approximately 60.68 billion yuan, including 100% equity of China Metallurgical Real Estate and other subsidiaries to China Minmetals [16] - Agricultural Bank of China approved a cash dividend distribution plan amounting to approximately 41.82 billion yuan, with a per-share cash dividend of 0.1195 yuan [23] - Midea Group completed a share repurchase totaling approximately 10 billion yuan, acquiring about 135 million shares [27]

Major Events - GuoXia Technology (02655) plans to conduct an IPO from December 8 to December 11, offering 33.85 million H-shares and introducing cornerstone investors such as Huikai Hong Kong [1] - Basilea Pharmaceutica AG (02616) has its drug Pujihua® (Pralsetinib Capsules) included in the National Medical Insurance Directory for 2025 [1] - Four Seasons Pharmaceutical (00460) sees its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Shanghai Pharmaceuticals (02607) successfully negotiates and includes Amisulpride Orally Disintegrating Tablets in the National Medical Insurance Directory [1] - Hansoh Pharmaceutical (03692) has its innovative drug Amelotex® approved for two new indications in the updated 2025 National Medical Insurance Directory [1] - Xiansheng Pharmaceutical (02096) sees EnzeShu® and EnDu® included in the updated National Medical Insurance Drug List [1] - Hutchison China MediTech (00013) has its drug Tazverik® included in the first edition of the National Commercial Health Insurance Innovative Drug List [1] - XuanZhu Biotechnology (02575) has its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Yino Pharmaceutical (02591) has its H-shares included in the list of eligible securities for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect [1] - China Metallurgical Group (01618) and its subsidiaries plan to sell non-core business assets for approximately 60.68 billion yuan, focusing on core businesses in metallurgical engineering, non-ferrous metals, and mining engineering [1] - Cambridge Technology (06166) intends to invest a total of 405 million yuan to acquire and subscribe for shares in the Yangzhong Happiness Home Venture Capital Partnership Fund [1] Operating Performance - Dongfeng Motor Group (00489) reports cumulative automobile sales of 1.697 million units in the first 11 months, a year-on-year decrease of approximately 0.3% [2] - New天绿色能源 (00956) achieves a cumulative power generation of 1,336.89 million MWh in the first 11 months, an increase of 8.04% year-on-year [2] - Longyuan Power (00916) reports a cumulative power generation of approximately 6,909.64 million MWh in the first 11 months, a year-on-year growth of 0.41% [2] - Baolong Real Estate (01238) records a total contract sales of approximately 6.666 billion yuan in the first 11 months, a year-on-year decline of 43.2% [2]

北京商报讯（记者 蔺雨葳）12月8日，东风汽车集团股份发布的公告显示，公司11月生产量总计21.6万 辆，1—11月累计产量达171万辆，累计同比增长1.9%；11月销量达19.6万辆，1—11月累计销量达170万 辆，累计同比下降0.3%。 ...

董事会决议待临时股东大会通过后，冯先生亦获委任为本公司总裁及上市规则第3.05条项下的授权代 表。冯先生获委任后，本公司执行董事杨青先生，将不再担任本公司授权代表职务。杨先生将继续担任 本公司执行董事、董事会主席、董事会薪酬委员会及提名委员会委员。 东风集团股份(00489)发布公告，董事会将根据本公司《公司章程》的有关规定建议委任冯长军先生为 本公司执行董事。关于董事委任的议案将提呈临时股东大会以普通决议案的方式予以审议批准。 ...

董事会决议待临时股东大会通过后，冯先生亦获委任为本公司总裁及上市规则第3.05条项下的授权代 表。冯先生获委任后，本公司执行董事杨青先生，将不再担任本公司授权代表职务。杨先生将继续担任 本公司执行董事、董事会主席、董事会薪酬委员会及提名委员会委员。 智通财经APP讯，东风集团股份(00489)发布公告，董事会将根据本公司《公司章程》的有关规定建议委 任冯长军先生为本公司执行董事。关于董事委任的议案将提呈临时股东大会以普通决议案的方式予以审 议批准。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 東風汽車集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：489） DONGFENG MOTOR GROUP COMPANY LIMITED* 暫停辦理股份過戶登記手續 東 風 汽 車 集 團 股 份 有 限 公 司（「本公司」）謹 訂 於 二 零 二 五 年 十 二 月 二 十 九 日 星 期 一 上 午 九 時 正 假 座 中 華 人 民 共 和 國（「中 國」）湖 北 省 武 漢 市 武 漢 經 濟 技 術 開 發 區 東 風 大 道 特 一 號（郵 編430056）舉 行 臨 時 股 東 大 會（「臨 時 股東大會」）。一 份 載 有 將 於 臨 時 股 東 大 會 上 提 呈 的 決 議 案 詳 情 的 通 函， 連 同 臨 時股東大 會 通 告，將 於 適 當 時 候 寄 發 予 本 公 司 股 東。 ...